Hydroxyurea Shortage Hits Sickle Cell Patients at Lira Hospital
Several sickle cell patients enrolled in the clinic at Lira Regional Referral Hospital (LRRH) are going without Hydroxyurea, a key crisis-management drug that helps prevent severe complications. Hydroxyurea is a disease-modifying medication for sickle cell anemia that reduces painful crises, hospitalizations, and acute chest syndrome. It works by increasing fetal hemoglobin (HbF), making red blood…